Lone Simonsen

Background

About Lone Simonsen

My research is highly interdisciplinary and involves colleagues and methodologies from fields ranging from history to mathematics. Over the past 25 years I have worked internationally as an epidemiologist and researcher. I am the center leader of PandemiX Center of Excellence (Center for Interdisciplinary Study of Pandemic Signatures), supported by the Danish National Research Foundation (DNRF). I have published ~350 peer-reviewed papers, book chapters, commentaries and letters, in collaboration with my amazing global network of researchers citations). I have worked on historical pandemics as a crucial source of data and understanding as an essential aspect to inform contemporary and future pandemic preparedness. In multiple studies of signature age patterns of mortality in the 1918 pandemic that have proposed hypotheses explaining observations of why the elderly were spared – this was later confirmed in the 2009 pandemic. I am trained in population genetics and epidemiology, and have worked internationally for +25 years, mainly at Centers for Disease Control and Prevention (CDC), The National Institutes of Health (NIH) and George Washington University in the United States, as well as at the WHO in Switzerland, before returning to Denmark in 2014. Initially I was a Professor of Historic Epidemiology at Faculty of Health and Medical Sciences at University of Copenhagen. Since 2018 I currently hold a position as Professor of Population Health Sciences in the Department of Science and Environment at Roskilde University, where I also studied in the 1980s. My research bridges multidisciplinary fields in science by applying sophisticated mathematical modelling of disease incidence to fundamental issues of the biology of pathogens. I have worked on COVID-19, pandemic and seasonal influenza, RSV, HIV/AIDS, tuberculosis, antibiotic resistance, SARS, big data modeling, e-health data and surveillance systems. In addition to this, I did research on modeling patterns and burdens of major historic and contemporary epidemics (from smallpox to ebola), and evaluating benefits of vaccine programs (influenza, pneumococcus, rotavirus). And in 2009 I led a 26-country WHO collaboration on influenza pandemic.